K Thway, C Fisher - Annals of diagnostic pathology, 2015 - Elsevier
Perivascular epithelioid cell tumors, or PEComas, are mesenchymal neoplasms composed of histologically and immunohistochemically distinctive epithelioid or spindle cells, which are …
JR Srigley, B Delahunt, JN Eble, L Egevad… - The American journal …, 2013 - journals.lww.com
The classification working group of the International Society of Urological Pathology consensus conference on renal neoplasia was in charge of making recommendations …
Patients with germline mutation of succinate dehydrogenase (SDH) subunit genes are prone to develop paraganglioma, gastrointestinal stromal tumor, and rarely renal cell carcinoma …
B Bhindi, RH Thompson, CM Lohse, RJ Mason, I Frank… - European urology, 2018 - Elsevier
Background While the probability of malignant versus benign histology based on renal tumor size has been described, this alone does not sufficiently inform decision-making in the …
S Fernández-Pello, M Hora, T Kuusk, R Tahbaz… - European urology …, 2020 - Elsevier
Context Little is known about the natural history of sporadic angiomyolipomas (AMLs); there is uncertainty regarding the indications of treatment and treatment options. Objective To …
SE Wobker, SR Williamson - Journal of kidney cancer and VHL, 2017 - ncbi.nlm.nih.gov
Oncocytoma is a well-defined benign renal tumor, with classic gross and histologic features, including a tan or mahogany-colored mass with central scar, microscopic nested …
W He, JC Cheville, PM Sadow, A Gopalan, SW Fine… - Modern Pathology, 2013 - Elsevier
Abstract The 2004 World Health Organization classification of tumors defines epithelioid angiomyolipoma of kidney as a potentially malignant mesenchymal neoplasm with reported …
ON Kryvenko, M Jorda, P Argani… - Archives of Pathology …, 2014 - meridian.allenpress.com
Context Eosinophilic renal neoplasms include a spectrum of solid and papillary tumors ranging from indolent benign oncocytoma to highly aggressive malignancies. Recognition of …
Simple Summary In the past decade, several novel renal neoplasms characterized by mutations in the tuberous sclerosis complex (TSC) or mechanistic target of rapamycin …